AIM ImmunoTech Inc’s recently made public that its CEO & President Equels Thomas K acquired Company’s shares for reported $2583.0 on Apr 04 ’25. In the deal valued at $0.06 per share,41,000 shares were bought. As a result of this transaction, Equels Thomas K now holds 1,899,029 shares worth roughly $4.65 million.
Then, Rodino Peter W III bought 500 shares, generating $44 in total proceeds. Upon buying the shares at $0.09, the COO, Secretary, Gen. Counsel now owns 401,762 shares.
Before that, Equels Thomas K bought 50,000 shares. AIM ImmunoTech Inc shares valued at $6,730 were divested by the CEO & President at a price of $0.13 per share. As a result of the transaction, Equels Thomas K now holds 1,858,029 shares, worth roughly $4.55 million.
Price Performance Review of AIM
On Friday, AIM ImmunoTech Inc [AMEX:AIM] saw its stock fall -3.66% to $2.45. Over the last five days, the stock has lost -9.26%. AIM ImmunoTech Inc shares have fallen nearly -93.31% since the year began. Nevertheless, the stocks have fallen -87.63% over the past one year. While a 52-week high of $37.80 was reached on 04/07/25, a 52-week low of $2.33 was recorded on 08/18/25.
Levels Of Support And Resistance For AIM Stock
The 24-hour chart illustrates a support level at 2.38, which if violated will result in even more drops to 2.30. On the upside, there is a resistance level at 2.55. A further resistance level may holdings at 2.64.
How much short interest is there in AIM ImmunoTech Inc?
A steep rise in short interest was recorded in AIM ImmunoTech Inc stocks on 2025-08-15, growing by 25643.0 shares to a total of 33819.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 8176.0 shares. There was a rise of 75.82%, which implies that there is a positive sentiment for the stock.
